Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESPONSE: Early Clinical Response Prediction in Breast Cancer
NCT05020860Phase 2Recruiting
- Sponsor
- Baylor Breast Care Center
- Start
- Apr 2023
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
Phase 2, open-label trial in breast cancer (4 arms), sponsored by Baylor Breast Care Center. Primary endpoint: Change in Clinical Tumor Measurement vs. Pathologic Response. Started Apr 2023; status: recruiting.
02
Conditions
breast cancer
Beyond the preview
Go deeper on NCT05020860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05020860.